FDA approval rate continues to surge, with 45 green lights for new drugs granted in 2015.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files
Molecular Diversity Open Access 08 September 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Mullard, A. 2015 FDA drug approvals. Nat Rev Drug Discov 15, 73–76 (2016). https://doi.org/10.1038/nrd.2016.15
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2016.15
This article is cited by
-
Kommentar zum 2016 Positionspapier der Europäischen Gesellschaft für Kardiologie (ESC) zu kardiovaskulären Komplikationen onkologischer Therapien
Der Kardiologe (2018)
-
The impact of structural biology in medicine illustrated with four case studies
Journal of Molecular Medicine (2018)
-
Strategies and challenges for the next generation of antibody–drug conjugates
Nature Reviews Drug Discovery (2017)
-
Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery
Journal of Cancer Research and Clinical Oncology (2016)
-
Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files
Molecular Diversity (2016)